Share

Obesity Appears to Increase the Risk of Developing Polycystic Ovary Syndrome

Obesity appears to increase the risk of developing polycystic ovary syndrome (PCOS), according to a study presented at ENDO 2023. An estimated 7% to 10% of all reproductive-aged women globally have PCOS. Women with PCOS have a hormonal imbalance and metabolism problems that may affect their overall health, appearance, and fertility. PCOS is associated with health...
Share

Light or Moderate Alcohol Use Does Not Guard Against Diabetes, Obesity

People who have just one or two drinks per day are not protected against endocrine conditions such as obesity and type 2 diabetes, according to a new study published in the Endocrine Society’s Journal of Clinical Endocrinology & Metabolism. Alcohol consumption is a significant public health concern because it is related to many medical conditions such as...
Share

Employees with Obesity May Have Higher Loss of Work Productivity

People with obesity may have lower work productivity due to increased risk of illness, contributing to increased costs for employers, according to industry-supported research being presented Saturday at ENDO 2023, the Endocrine Society’s annual meeting, in Chicago, Ill. Obesity is a significant public health issue affecting approximately 42% of people in the United States. Employees...
Share

Weight Loss with Combination Anti-Obesity Medications Approximates that Achieved with Bariatric Surgery

Weight loss achieved through the use of a combination of anti-obesity medications (AOMs) can approach the reduction seen in bariatric surgery, according to a paper recently published in JCEM Case Reports. Researchers led by Priya N. Patel, MD, of the Center for Pediatric Obesity Medicine at the University of Minnesota Medical School in Minneapolis point...
Share

ENDO 2023 Preview:  Junk Food

Maria 3 Maria T. Balhara discusses her ENDO 2023 sessions on food’s impact on human health   A three-session symposium on our everchanging food environment, “Impact of the Changes in Food Environment in the Development of Obesity,” looks at endocrine-disrupting chemicals, climate change, and processing methods and how these factors impact endocrine health, specifically obesity. Endocrine News talks...
Share

The Agonists and the Ecstasy

The popularity of GLP-1 agonists to treat obesity has been skyrocketing in recent months, leading to both shortages and price increases. However, as more patients make their voices heard and doctors begin to prescribe them, obesity could become easier to treat or even cure.   Thanksgiving is a time for family, fellowship, and food. But for...